Scientists at Northwestern Medicine in Chicago, Illinois, used genome-wide CRISPR interference screening to identify genetic factors that explain why some people with Parkinson's-linked gene variants develop the disease and others do not.
The study was published in the journal Science.
The Brighter Side of News has more information.